CPT® Code 0400T

Deleted

1. Indications

The multi-spectral digital skin lesion analysis is indicated for the evaluation of clinically atypical cutaneous pigmented lesions. This procedure is particularly useful for the following conditions:

• Clinically Atypical Lesions - Lesions that exhibit characteristics that are not typical and may require further investigation to determine their nature.
• Early Melanomas - The procedure assists in the early detection of melanoma, a serious form of skin cancer that can develop from atypical moles.
• High-Risk Melanocytic Atypia - Identification of lesions that show signs of atypical melanocytic cells, which may indicate a higher risk for developing melanoma.
• Suspicious Pigmented Lesions - Lesions that appear suspicious based on visual examination and may warrant further diagnostic evaluation.

2. Procedure

The multi-spectral digital skin lesion analysis involves several key procedural steps to ensure accurate assessment of the skin lesions. The process begins with the patient being positioned comfortably, and the area of interest is prepared for examination. The healthcare provider then utilizes a handheld scanner that emits multi-spectral light, which includes wavelengths from visible light to near-infrared. This scanner is carefully placed over the skin lesion, allowing the light to penetrate the lesion to a depth of up to 2.5 millimeters. As the light interacts with the skin cells, it captures detailed information regarding the cell morphology beneath the surface. This data is then transmitted to a computer software program designed to analyze the information collected during the scan. The software processes the data and organizes it into an algorithm that evaluates the characteristics of the lesion. Each lesion is assigned an algorithmic score, which ranges from less than 0 to 0 or more, indicating the level of suspicion regarding morphological disorganization. If the score indicates a positive result, suggesting a high degree of morphological disorganization, the healthcare provider will recommend further histological examination, such as a biopsy, to confirm the diagnosis. In cases where the score is negative, indicating low suspicion, the lesions can be monitored over time for any changes that may occur. This comprehensive approach allows for effective classification and management of skin lesions, enhancing the ability to detect potential malignancies early.

3. Post-Procedure

After the multi-spectral digital skin lesion analysis, the healthcare provider will discuss the results with the patient, explaining the algorithmic score assigned to each lesion. If any lesions are identified as positive and warrant further investigation, the provider will outline the next steps, which may include scheduling a biopsy or additional diagnostic tests. For lesions that are scored negatively, the provider may recommend a follow-up plan to monitor the lesions over time, ensuring that any changes are promptly addressed. Patients may be advised on signs to watch for that could indicate changes in the lesions, such as alterations in size, shape, color, or texture. Overall, the post-procedure care focuses on ensuring that patients are informed and that any necessary follow-up actions are clearly communicated to maintain optimal skin health.